
Sign up to save your podcasts
Or
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
4.7
16081,608 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
4,095 Listeners
483 Listeners
3,183 Listeners
828 Listeners
2,184 Listeners
1,369 Listeners
3,373 Listeners
806 Listeners
1,493 Listeners
930 Listeners
2,288 Listeners
582 Listeners
380 Listeners
867 Listeners
1,530 Listeners
400 Listeners
231 Listeners